- Report
- June 2024
- 76 Pages
Global
From €1282EUR$1,400USD£1,090GBP
- Report
- February 2025
- 100 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- April 2025
- 175 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- April 2025
- 175 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- April 2025
- 175 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- April 2025
- 175 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- April 2025
- 200 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- May 2024
- 180 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- March 2022
- 55 Pages
Global
From €1832EUR$2,000USD£1,557GBP
€3664EUR$4,000USD£3,114GBP
- Report
- March 2022
- 98 Pages
Global
From €3500EUR$4,093USD£3,079GBP
- Report
- March 2024
- 84 Pages
Global
From €3500EUR$4,093USD£3,079GBP
- Book
- February 2024
- 800 Pages
- Book
- January 2024
- 800 Pages

Plasma Medicine is a field of healthcare services that focuses on the use of plasma-based therapies to treat a variety of medical conditions. Plasma is the liquid component of blood, and it contains proteins, antibodies, and other molecules that can be used to treat a variety of diseases. Plasma-based therapies are used to treat conditions such as cancer, autoimmune diseases, and genetic disorders. Plasma-based therapies can also be used to treat infections, wounds, and burns.
Plasma Medicine is a rapidly growing field of healthcare services, with new treatments and technologies being developed to improve patient outcomes. Plasma-based therapies are often used in combination with other treatments, such as chemotherapy and radiation therapy, to provide a more comprehensive approach to patient care.
Some companies in the Plasma Medicine market include Grifols, CSL Behring, Octapharma, Kedrion, and Biotest. Show Less Read more